The immune-dependent anti-tumor activity of IAPi was more profound towards LKB1-KD cells than that towards the LKB1-WT counterparts (Supplementary Fig. S2A–C), which were already sensitive to immune killing, suggesting IAP as a potential tumor-intrinsic factor that controls immune sensitivity of tumors with mutated LKB1. Here, STK11 is linked to neoplasm.